We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ADIL market cap is 2.83M. The company's latest EPS is USD -10.4525 and P/E is -0.22.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -554k | -5.87M | -2.92M | -825k | -1.36M |
Net Income | -476k | -5.5M | -2.91M | 1.09M | -1.39M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -6.99M | -8.25M | -10.93M | -17.74M | -13.32M |
Net Income | -11.63M | -8.59M | -10.89M | -19.42M | -12.73M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 7.74M | 5.73M | 3.9M | 3.78M | 2.87M |
Total Liabilities | 2.33M | 2.46M | 2.46M | 462k | 528k |
Total Equity | 5.41M | 3.28M | 1.44M | 3.32M | 2.34M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 4.7M | 7.68M | 5.49M | 7.48M | 5.73M |
Total Liabilities | 258k | 539k | 1.51M | 3.97M | 2.46M |
Total Equity | 4.44M | 7.14M | 3.99M | 3.51M | 3.28M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -9.44M | -11.19M | -2.3M | -4.19M | -5.58M |
Investing | N/A | N/A | N/A | 800k | 1.15M |
Financing | 9.13M | 9.13M | 610k | 610k | 748k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.5M | -6.34M | -7.63M | -11.95M | -11.19M |
Investing | N/A | N/A | -350k | -34k | N/A |
Financing | 6.35M | 9.25M | 5.61M | 13.64M | 9.13M |
Market Cap | 2.83M |
Price to Earnings Ratio | -0.22 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.71 |
Price to Book Ratio | 0.86 |
Dividend Yield | - |
Shares Outstanding | 1.22M |
Average Volume (1 week) | 9.07M |
Average Volume (1 Month) | 7.61M |
52 Week Change | -69.07% |
52 Week High | 14.00 |
52 Week Low | 0.765 |
Spread (Intraday) | 0.49 (18.15%) |
Company Name | Adial Pharmaceuticals Inc |
Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
Website | https://www.adialpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions